Gastrointestinal Tolerance of Under-five Children With Severe Acute Malnutrition to ONS Compared to F-75/F-100
1 other identifier
interventional
108
1 country
2
Brief Summary
The primary outcome of the study is to identify gastrointestinal tolerance of under-five children with severe acute malnutrition to ready-to-drink high energy (1.5 kcal/ml) and standard energy (1 kcal/ml) oral nutrition supplement (ONS) compared to Formula-75/Formula-100. The secondary outcomes of the study are weight gain, electrolyte profile and plasma amino acid profile at the beginning and the end of stabilization phase. In this randomized, controlled trial, 108 patients with severe acute malnutrition will be enrolled. Patients are randomly assigned to 3 groups (Formula-75/Formula-100, high energy ONS, and standard energy ONS) to undergo a two-week treatment. In order to ensure an adequate intake, nasogastric-tube will be placed for home enteral nutrition for at least throughout the two-week study period. Parent or caregiver will be asked to record daily intake, vomit, and defecation score using Bristol stool chart.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2019
CompletedFirst Submitted
Initial submission to the registry
January 12, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedDecember 2, 2021
December 1, 2021
1.6 years
January 12, 2021
December 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gastrointestinal tolerance for bowel movement
Frequency of bowel movement per day and description of stool consistency (Bristol stool chart)
14 days
Gastrointestinal tolerance for vomit
Frequency of vomit per day and volume of vomit
14 days
Secondary Outcomes (6)
Weight gain
14 days
Height gain
14 days
Prevalence of hypokalemia
Day 1 and day 3
Prevalence of hypophosphatemia
Day 1 and day 3
Prevalence of hypomagnesemia
Day 1 and day 3
- +1 more secondary outcomes
Study Arms (3)
Formula-75/Formula-100
ACTIVE COMPARATORThis arm is the control. Formula-75/Formula-100 are the standard formula recommended by WHO to treat severely malnourished children.
High Energy Oral Nutrition Supplement
EXPERIMENTALHigh energy oral nutrition supplement (ONS) has energy density of 1.5 kcal/ml, with protein-energy ratio of 8.9% and complete micronutrients. It is also named as enteral formula and can be used as a sole source of nutrition. It comes as a ready-to-drink bottled package of 200 mL each. The nutrition fact fulfills the requirement of BPOM (Indonesian Food and Drug Authority) for Special Medical Purpose. The ready-to-drink formula is a safe option to treat severely malnourished patient in terms of hygiene assurance of formula. In Indonesia, many severely malnourished children come from areas with poor access to clean water and proper sanitation. The high energy ONS is beneficial for children who cannot tolerate large volume of feeding.
Standard Energy Oral Nutrition Supplement
EXPERIMENTALStandard energy oral nutrition supplement (ONS) has energy density of 1 kcal/ml, with protein-energy ratio of 9.6% and complete micronutrients. It is also named as enteral formula and can be used as a sole source of nutrition. It comes as a ready-to-drink bottled package of 200 mL each. The nutrition fact fulfills the requirement of BPOM (Indonesian Food and Drug Authority) for Special Medical Purpose. The ready-to-drink formula is a safe option to treat severely malnourished patient in terms of hygiene assurance of formula. In Indonesia, many severely malnourished children come from areas with poor access to clean water and proper sanitation.
Interventions
Oral Nutrition Supplement (ONS) or enteral formula is a formula intended to treat individuals who are unable to meet their nutritional requirements through oral diet alone. European Food Safety Authority described ONS as a formula with caloric density \>0.9 kcal/mL. Formula with caloric density of \>1.2 kcal/mL is categorized as high energy ONS. This intervention has caloric density of 1.5 kcal/mL.
Oral Nutrition Supplement (ONS) or enteral formula is a formula intended to treat individuals who are unable to meet their nutritional requirements through oral diet alone. European Food Safety Authority described ONS as a formula with caloric density \>0.9 kcal/mL. This intervention has caloric density of 1 kcal/mL and it is categorized as standard energy ONS.
Formula-75/Formula-100 is a special therapeutic foods to treat children with severe acute malnutrition. WHO designed F75 as a starter formula for stabilization phase with 75 kcal/100 mL, then it is continued with F100 for rehabilitation phase with 100 kcal/100 mL Formula-75 and Formula-100 are made according to recipe from WHO. The ingredients are skimmed milk powder, coconut oil, and sugar. Mineral mix is added, i.e. 2 ml every 100 ml of formula. The composition of F-75: Skimmed milk 25 g, coconut oil 100 g, sugar 30 g, mineral mix 20 ml, add water to 1000 ml The composition of F-100: Skimmed milk 80 g, coconut oil 50 g, sugar 60 g, mineral mix 20 ml, add water to 1000 ml
Eligibility Criteria
You may qualify if:
- Children aged 12-60 months
- Weight for length/height z score \< -3 (WHO 2006)
- Not on nutritional treatment of severe acute malnutrition for the last 1 month
You may not qualify if:
- Not willing to take part in this study
- Having diarrhea
- Diagnosed with malignancy or suspected malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indonesia Universitylead
- PT. Nutricia Medical Nutritioncollaborator
Study Sites (2)
RSUPN Dr. Cipto Mangunkusumo
Jakarta, DKI Jakarta, 10430, Indonesia
RSUP Fatmawati
Jakarta, DKI Jakarta, 12430, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klara Yuliarti, MD
Department of Pediatric, Faculty of Medicine, University of Indonesia/ Cipto Mangunkusumo Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 12, 2021
First Posted
January 20, 2021
Study Start
September 4, 2019
Primary Completion
April 15, 2021
Study Completion
April 15, 2021
Last Updated
December 2, 2021
Record last verified: 2021-12